Targeted Phytotherapy For Reactive Oxygen Species Linked Oral Cancer
Nikita Sivakumar1, R. V. Geetha2, Vishnu Priya3, Gayathri R4, Dhanraj Ganapathy5*
1 Intern, Department of Prosthodontics, Saveetha Dental College and Hospitals, Chennai - 600 077, India.
2 Assistant Professor, Department of Microbiology, Saveetha Dental College and Hospitals, Chennai - 600 077, India.
3 Professor and Head, Department of Biochemistry, Saveetha Dental College And Hospitals, Saveetha Institute Of Medical And Technical Sciences Chennai, India.
4 Reader, Department of Physiology, Saveetha Dental College and Hospitals, Chennai - 600 077, India.
5 Professor and Head, Department of Prosthodontics, Saveetha Dental College And Hospitals, Saveetha Institute Of Medical And Technical Sciences Chennai, India.
*Corresponding Author
Dhanraj Ganapathy,
Professor and Head, Department of Prosthodontics, Saveetha Dental College,Chennai, 600 077, India.
E-mail: dhanraj@saveetha.com
Received: January 12, 2021; Accepted: January 22, 2021; Published: January 28, 2021
Citation:Nikita Sivakumar, R. V. Geetha, Vishnu Priya, Gayathri R, Dhanraj Ganapathy. Targeted Phytotherapy For Reactive Oxygen Species Linked Oral Cancer. Int J Dentistry Oral Sci. 2021;8(1):1425-1429. doi: dx.doi.org/10.19070/2377-8075-21000284
Copyright: Dhanraj Ganapathy©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Medicinal plants play a major role in medical and health needs. In developing countries, there is an increasing attempt to incorporate the traditional medicines, especially herbal preparations in the local healthcare systems and people are increasingly turning to herbal medicine. Plant derived therapies are suggested for its cost effectiveness, fewer side effects and lesser frequencies of resistance. The aim of this study is to understand the free radical scavenging properties of selected Indian medicinal plants and their cytotoxicity against oral cancer cell lines.The plant parts were shade dried, powdered and extracted using methanol solvent. These extracts were analyzed for the free radical scavenging properties in Cell lines by Nitric oxide assay. Further, an MTT assay was performed to understand the cytotoxicity of the extracts. Data showed a significant percentage of inhibition of the free radicals and cytotoxicity against the oral cancer cell lines.Selected plants have been shown to possess inhibitory potentials against ROS-linked oral cancers and may be used for targeted phytotherapy.
2.Background
3.Materials And Method
4.Results
5.Discussion
6.Conclusion
7.References
Keywords
Phytotherapy; Herbal; ROS; Cytotoxicity; Cancer; Free Radicals.
Introduction
The great advances in medicine for synthetic drugs, might have
made us overlook the healing power of a “natural” source; the
plants [14]. However, since the consumer’s interest is gradually
shifting towards the more “natural” and “safer” alternative, Phytotherapy
has once again come back to its peak of research [8].
In this research, two plant extracts will be used; Cassia fistula and
Cassia alata. They belong to the same family, Fabaceae [4]. Cassia
alata which is also known as Sennaalata, is a medicinal plant used
as vermicide, astringent, purgative, expectorant and to treat skin
diseases. It has demonstrated effective broad spectrum antibacterial,
anticandidal, and antifungal activities in several laboratory
studies over the years [12]. It also relieves pain, reduces inflammation,
helps in digestion and repels insects. The parts commonly
used for medicinal purposes are the leaves and the bark [18, 6].
On the other hand, Cassia Fistula also has various medicinal uses.
It is commonly known as Amaltas. They are native to South-East
Asia and generally found in the Himalayas [20]. Cassia Fistula true
in a whole is very useful; the root bark contains tannin, phlobaphenes
and oxy anthraquinone, the pulp containing rhein, a volatile
oil and a resinous substance and notably the fruits of cassia fistula
are used in the Indian Pharmaceutical codex. Cassia Fistula extracts
are commonly used to treat Aguesia, skin disorders, intestinal
disorders, common cold and constipation [1].
Reactive oxygen species (ROS) may be stimulated by oxidative
stress, nutrient starvation, mitochondrial toxins and hypoxia
which eventually induces carcinogenesis [2]. In this research, two
plant extracts will be used to study its phytochemical analysis and
its role in phytotherapy for reactive oxygen species linked to oral cancer [17, 10].
Materials And Method
Fresh Leaves of Cassia alata and Cassia fistula were collected,
shade dried and powdered. The powdered (100gm) was extracted
three times by Cold percolation method with 300 ml of Methanol
at room temperature for 72hrs. The filtrates were concentrated
under reduced pressure at 40ºC and stored in the refrigerator at
2-8ºC for use in subsequent experiments.
The yield (g/100g of sample) of the C.alata and C.fistula extracts
were 4.915 g and 3.496 g respectively.
In this research, 3 analyses were carried out; Phytochemical Tests,
Nitric Oxide Assay and MTT assay.
The phytochemical tests included tests for carbohydrates, tannins,
saponins, flavonoids, alkaloids, quinones, glycosides, cardiac
glycosides, terpenoids, Steroids and phytosteroids, phenols, coumarins,
Phlobatannins, Anthraquinones.
1. Test for Carbohydrates:
To 2ml of plant extract, 1ml of Molisch’s reagent and few drops
of concentrated sulphuric acid were added. Presence of purple or
reddish color indicates the presence of carbohydrates [15].
2. Test for Tannins:
To 1ml of plant extract, 2ml of 5% ferric chloride was added.
Formation of dark blue or greenish black indicates the presence
of tannins [19].
3. Test for Saponins:
To 2ml of plant extract, 2ml of distilled water was added and
shaken in a graduated cylinder for 15 minutes lengthwise. Formation
of 1cm layer of foam indicates the presence of saponins [5].
Test for Flavonoids.
To 2ml of plant extract, 1ml of 2N sodium hydroxide was added.
Presence of yellow color indicates the presence of flavonoids.
4. Test for Cardiac Glycosides:
To 0.5ml of extract, 2ml of glacial acetic acid and few drops of
5% ferric chloride were added. This was under layered with 1 ml
of concentrated sulphuric acid. Formation of brown ring at the
interface indicates presence of cardiac glycosides.
5. Test for Terpenoids:
To 0.5ml of extract, 2ml of chloroform was added and concentrated
sulphuric acid was added carefully. Formation of red brown
color at the interface indicates presence of terpenoids.
6. Test for Phlobatannins:
To 1ml of plant extract few drops of 2% HCL was added; the appearance
of red color precipitate indicates the presence of phlobatannins.
7. Test for Anthraquinones:
To 1ml of plant extract few drops of 10% ammonia solution was
added, appearance pink color precipitate indicates the presence
of anthraquinones [9].
8. Test for Alkaloids:
To 2ml of plant extract, 2ml of concentrated hydrochloric acid
was added. Then few drops of Mayer’s reagent were added. Presence
of green color or white precipitate indicates the presence of
alkaloids [16].
9. Test for Quinones:
To 1ml of extract, 1ml of concentrated sulphuric acid was added.
Formation of red color indicates the presence of quinones.
10. Test for Phenols:
To 1ml of the extract, 2ml of distilled water followed by few
drops of 10% ferric chloride was added. Formation of blue or
green color indicates presence of phenols.
11. Test for CoumarinsL
To 1 ml of extract, 1ml of 10% NaOH was added. Formation of
yellow color indicates presence of coumarins [21].
12. Test for Glycosides:
To 2ml of plant extract, 3ml of chloroform and 10% ammonia
solution was added. Formation of pink color indicates presence
of glycosides [3].
13. Tests for Steroids and Phytosteroids:
To 1ml of plant extract equal volume of chloroform is added and
subjected with few drops of concentrated sulphuric acid appearance
of brown ring indicates the presence of steroids and appearance
of bluish brown ring indicates the presence of phytosterols.
[13].
The nitric oxide assay was performed as described previously
with slight modification. After pre-incubation of KB cells (1.5 ×
105 cells/mL) with LPS (1μg/ml) for 24h, the plant extracts were
added and incubated for 48h.
The quantity of nitrite in the culture medium was measured as an
indicator of NO production. Amount of nitrite, a stable metabolite
of NO, was measured using Griess reagent (1% sulfanilamide
and 0.1% naphthylethylenediaminedihydrochloride in 2.5% phosphoric
acid). Briefly, 100 μl of cell culture medium was mixed with
100 μl of Griess reagent. Subsequently, the mixture was incubated
at room temperature for 10 min and the absorbance at 540 nm
was measured in a microplate reader (Tecan, Switzerland). Fresh culture medium was used as a blank in every experiment [22].
% of inhibition = (Control OD-Sample OD)/Control OD X 100.
The MTT assay (Mossman, 1983) is based on the ability of live
but not dead cells to reduce a yellow tetrazolium dye to a purple
formazan product. Cells were maintained in DMEM medium,
supplemented with 10% Fetal Bovine Serum, at 37oC in humidified
atmosphere with 5% CO2. The cells were plated in 96 well flat
bottom tissue culture plates at a density of approximately 1.2X
104 cells/well and allowed to attach overnight at 37oC. The medium
was then discarded and cells were incubated with different
concentrations of the C.fistula extract (25, 50, 75, 100 &150 μg)
for 24 hours. After the incubation, medium was discarded and
100μl fresh medium was added with 10μl of MTT (5mg/ml). After
4 hours, the medium was discarded and 100μl of DMSO was
added to dissolve the formazan crystals. Then, the absorbance
was read at 570 nm in a microtiter plate reader. Cyclophosphamide
was used as positive control.
Cell survival was calculated by the following formula:
Viability % = (Test OD/ Control OD) X 100
Cytotoxicity % = 100 – Viability%.
Results
Discussion
Preliminary phytochemical analysis of methanolic extract of Cassia
alata and Cassia fistula was performed using standard tests. The
phytoconstituents present in Cassia fistula and Cassia alata were
found to be carbohydrates, tannins, flavonoids, quinones, terpenoids,
coumarins and phenols. Herbal extracts contains many
secondary metabolites, which contribute significantly towards the
biological activities of medicinal plants such as hypoglycemic, an-tidiabetic, antioxidant, antimicrobial, anti-inflammatory, anti carcinogenic,
antimalarial, anticholinergic, anti leprosy activities etc.
[11]. There is more to explore of the properties of Cassia Fistula
and Cassia Alata extracts which may be a thrust area for the future
research in the drug designing industry.
Nitric Oxide is an inhibitor of neuronal signaling, platelet aggregation
and regulated cell mediated toxicity. It is a free radical species
present in tissues. The ability of these two plants extracts in
scavenging Nitric Oxide radical was evaluated and it was found
that Cassia fistula has better scavenging capacity when compared
with Cassia alata.
Cytotoxicity analysis by using varying concentration of Cassia fistula
and Cassia alata extract was done. MTT assay is a colorimetric
assay for all cell metabolic activities. NAD (P) H dependent
cellular oxide-reduction enzymes may, under defined conditions,
reflect the number of viable cells present.
Examples of few commercially used extracts are Chamomillarecutita
for its property of mild gastrointestinal complaints and
PunicaGranatum for chronic periodontitis. Other few essential
phytotherapy products are such as lemon grass oil which has
shown its significance as an antidiabetic and antioxidant agent.
In addition to that, Achyranthes aspera leaf extracts have shown
anthelmintic activity which has a purpose of fighting against parasites
which cause the development of diseases such as tuberculosis
and malaria [7].
Conclusion
Screening of the two medicinal plants clearly reveals that the maximum
classes of phytoconstituents are present in Cassia fistula
and Cassia alata. Hence, the above plant extract could be explored
for its highest therapeutic efficacy by pharmaceutical companies
in order to develop safe drugs for various ailments. Further research
and development can be done for better understanding of
their therapeutic effect.
The extracts exhibited increasing cytotoxicity with increasing
concentration. This study confirms the antioxidant and cytotoxicity
potential of Cassia Fistula and Cassia Alata extracts. There
is more to explore of the properties of Cassia fistula and Cassia
alata extracts which may be a thrust area for the future research in
the drug designing industry.
References
- Bahorun T, Neergheen, VS, Aruoma, OI. ‘Phytochemical constituents of Cassia fistula’, African Journal of Food, Agriculture, Nutrition and Development. 2011.doi: 10.4314/ajfand.v4i13.71772.
- Bhalodia NR, Shukla VJ. Antibacterial and antifungal activities from leaf extracts of Cassia fistula l.: An ethnomedicinal plant. J Adv Pharm Technol Res. 2011 Apr;2(2):104-9.Pubmed PMID: 22171301.
- Dontha, S, Kamurthy H, Manthripragada, B.‘Phytochemical Screening and Evaluation of in-vitro Anti-oxidant Activity of Extracts of Ixorajavanica D. C Flowers’, American Chemical Science Journal.2016; 1–9. doi: 10.9734/ acsj/2016/20661.
- Van Dyck E, Meheus A, Piot P. Laboratory diagnosis of sexually transmitted diseases. World Health Organization; 1999.
- Farnsworth NR, Loub WD, Blomster RN, Gorman M. Pericyclivine, a new Catharanthus alkaloid. J. Pharm. Sci. 1964 Dec 1;53(12):1558.
- Habtemariam S. Medicinal foods as potential therapies for Type-2 diabetes and associated diseases: the chemical and pharmacological basis of their action. Academic Press; 2019 Jun 8.
- Hasan K, Lakshmi T, Rathinam TK. Preliminary Phytochemical Analysis and In vitro Anti-helmenthic activity of Achyranthesaspera Leaf extract. Pharmacogn. J. 2015;7(6):397-399.
- Heinrich M, Williamson EM, Gibbons S, Barnes J, Prieto-Garcia J. Fundamentals of Pharmacognosy and Phytotherapy E-Book. Elsevier Health Sciences; 2017 Nov 24.
- Jana S, Shekhawat GS. Phytochemical analysis and antibacterial screening of in vivo and in vitro extracts of Indian medicinal herb: Anethumgraveolens. Res J. Med. Plants . 2010;4(4):206-12.
- Jothy SL, Zakariah Z, Chen Y, Sasidharan S. In vitro, in situ and in vivo studies on the anticandidal activity of Cassia fistula seed extract. Molecules. 2012 Jun 7;17(6):6997-7009.Pubmed PMID: 22678414.
- Karpagam GN, Gayathri R, Vishnupriya V. Bioactivity analysis of lemongrass oil. Asian J. Research Chem. 2016 Jul 1;9(7):903.
- Khan MR, Kihara M, Omoloso AD. Antimicrobial activity of Cassia alata. Fitoterapia. 2001 Jun 1;72(5):561-4.
- Kolawole OM, Oguntoye SO, Agbede O, Olayemi AB. Studies on the efficacy of Brideliaferrugineabenth bark extract for domestic wastewater treatment. Bull ChemSoc Ethiop. 2007 Jul 10;21(2):205-11.
- Mills S, Bone K. Principles and practice of phytotherapy. Modern herbal medicine. Churchill Livingstone; 2000.
- Muñoz K, Maciuk A, Bravo K, Londoño J, Osorio E, Figadère B. Screening of Colombian plants for antimalarials using LC-Bio-MS. Planta Med. 2008 Jul;74(09):PC86.
- Nayik GA, Gull A. Antioxidants in Vegetables and Nuts-Properties and Health Benefits. Springer Singapore Pte. Limited.2020.
- Nuijts RM, Nuijts RM. Ocular toxicity of intraoperatively used drugs and solutions. Kugler Publications; 1995.
- Panda SK, Padhi LP, Mohanty G. Antibacterial activities and phytochemical analysis of Cassia fistula (Linn.) leaf. J Adv Pharm Technol Res. 2011 Jan;2(1):62-7.Pubmed PMID: 22171295.
- Richardson PM. Phytochemical methods: a guide to modern techniques of plant analysis. Brittonia. 1990;2(42):115.
- Varghese GK, Bose LV, Habtemariam S. Antidiabetic components of Cassia alata leaves: identification through α-glucosidase inhibition studies. Pharm. Biol. 2013 Mar 1;51(3):345-9.
- Wisniak J. The chemistry and technology of jojoba oil. Am Oil Chem Soc.1987.
- Xie G, Schepetkin IA, Siemsen DW, Kirpotina LN, Wiley JA, Quinn MT. Fractionation and characterization of biologically-active polysaccharides from Artemisia tripartita. Phytochemistry. 2008 Apr;69(6):1359-71.Pubmed PMID: 18325553.